NeuColl

NeuColl was a medical technology company specializing in the development of collagen-based bone graft substitutes for orthopedic and spinal applications. Its flagship product, Healos, is a bone graft replacement material composed of a collagen-hydroxyapatite matrix designed to mimic the structure of natural bone. The company's technology focuses on providing a scaffold that supports bone growth and integration in surgical procedures such as spinal fusions. NeuColl was acquired by Zimmer Holdings in 2008 to enhance Zimmer's orthobiologics portfolio. The Healos product line continues to be a significant component of the orthobiologics market under the Zimmer Biomet brand.